MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeBusinessCould These Devices Someday Replace Drugs? Brainsway Deep TMS

Could These Devices Someday Replace Drugs? Brainsway Deep TMS

Brainsway Deep TMS

Brainsway's Deep Transcranial Magnetic Stimulation (TMS) technology treats major depressive disorder in patients who didn't get good results from antidepressant drugs. The system uses a helmet containing the company's proprietary H-coil to deliver magnetic stimulation to deep brain tissue, which can help regulate mood. It was cleared by FDA in 2013. 
             

[video courtesy of CEFALY TECHNOLOGY]  

TAGS: Regulatory & Quality
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
IMEast.png
Medical Design & Manufacturing (MD&M) East 2023
Agreement with a handshake
Scivita Medical Partners with Boston Sci to Broaden Single-use Videoscope Demand
Mar 29, 2023
Calendar pages
This Week Last Year in Medtech: March 19-25
Mar 23, 2023
Financial decrease
Pear Therapeutics Seeks Strategic Alternatives as Purse Strings Tighten
Mar 17, 2023